The traditional framework for clinical breast cancer classification encompasses three major types: (1) luminal ER-positive and PR-positive (additionally subdivided into luminal types A and B based on histochemical staining for the proliferation marker protein Ki-67 (MKI67) or genetic profiling); (2) HER2-positive; (3) triple-negative breast cancer (TNBC) [56]. Here, PGR is linked to breast cancer.